MindMaze Therapeutics Holding S.A. (0QKQ.L) LSE
0.38
+0.00263(+0.70%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
MindMaze Therapeutics Holding S.A.
Address
Avenue de Secheron 15
Geneva, 1202
Switzerland
Phone
+41 21 532 08 60
Sector
Healthcare
Industry
Biotechnology
Employees
31
First IPO Date
January 18, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Zachery W. Henderson | Chief Executive Officer | 542,580 | 1973 |
| Zach W. Henderson | Chief Executive Officer | 542,580 | N/A |
| Paolo Galfetti | Chief Business Officer | 526,057 | 1965 |
| Alexandre Capet | Chief Operating & Strategy Officer | 0 | 1973 |
| Jeremy Meinen | Chief Financial Officer | 0 | 1989 |
| Frédéric Condolo | Chief Technology Officer | 0 | 1973 |
Description
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
